Neovii Biotech
Germany - GrafelfingBiotechnology
Focus: Neovii Biotech is a German biotechnology company specializing in stem cell therapy and biologics, focused on cell and gene therapy development for oncology, immunology, and rare diseases.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Neovii Biotech
AI assessmentNot HiringNo open roles listed right now. Follow Neovii Biotech to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthStrong
Pipeline
Late-stage
6 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Post-LOE
Marketed Phase 4 product indicating established commercial presence, though likely mature with limited growth trajectory.
Pipeline & Clinical Trials
Help build intelligence for Neovii Biotech
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.